
Last updated: 2026-09-23 21:50:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
GlucoTrack, Inc. (GCTK) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $2.02, with a market capitalization of $1.84M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.01 to $136.29. This page covers its latest market performance, valuation, price trends and company information.
$1.84M | |
$2.23 | |
$381,600.00 | |
$2.01 | |
$2.22 | |
276.01K | |
767.61K | |
-- | |
$136.29 | |
$2.01 | |
-- | |
-- |
GlucoTrack, Inc. (GCTK) is trading at $4.53 in after-hours trading as of 2026-09-23 21:49:00, up 104.10% ($2.31) from the regular-session close of $2.22.
After-hours trading shows how investors are pricing GCTK after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, GlucoTrack, Inc. (GCTK) moved from $2.45 to $2.02, representing a decline of 17.67% ($0.43).
The stock traded between $2.01 and $2.67 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 128.23 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0.0%
GCTK is currently trading at $2.02, placing it 0.0% of the way from its 52-week low of $2.01 to its 52-week high of $136.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 15 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of GlucoTrack, Inc. (GCTK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.